Zhiliang Gao

Zhiliang Gao

Auto-generated profile, based on publicly available information

Zhiliang Gao

Key Laboratory of Colloid and Interface Chemistry of the Ministry of Education, School of Chemistry and Chemical Engineering, Shandong University, Jinan, Shandong 250100, China

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2022 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
YTYuan Tian
Yuan Tian
ZGZhiliang Gao
Zhiliang Gao
NWNing Wang
Ning Wang
MHMing Hu
Ming Hu
YJYi Ju
Yi Ju
JCJiwei Cui
Jiwei Cui

7 August 2020 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
QYQun Yu
Qun Yu
YTYuan Tian
Yuan Tian
MLMeng Li
Meng Li
YJYuan Jiang
Yuan Jiang
HSHaifeng Sun
Haifeng Sun
JCJiwei Cui
Jiwei Cui
Scalable mineralization of zeolitic imidazolate framework-8 nanoparticles with versatility of cargo encapsulation and excellent colloidal dispersibility and stability is engineered using poly(ethylene glycol) as the mineralizer for therapeutic delivery.

2 August 2021 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
HMHanxiao Mei
Hanxiao Mei
ZGZhiliang Gao
Zhiliang Gao
KZKaijie Zhao
Kaijie Zhao
MLMengqi Li
Mengqi Li
Muthupandian AshokkumarMuthupandian Ashokkumar
Muthupandian Ashokkumar
Jingcheng HaoJingcheng Hao
Jingcheng Hao

19 October 2015 in Oncotarget
Verified
Journal Article
Open access
PDF file
PWPeipei Wang
Peipei Wang
SCSong Chen
Song Chen
HFHe Fang
He Fang
XWXiaojuan Wu
Xiaojuan Wu
DCDabiao Chen
Dabiao Chen
CXChan Xie
Chan Xie
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Peipei Wang1, 2, *, Song Chen3, *, He Fang4, *, Xiaojuan Wu1, Dabiao Chen1, Liang Peng1, Zhiliang Gao1, 2, Chan Xie1, 2 1Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong Province, China 2Key Laboratory of Tropical Disease Control, Ministry of Education, Sun Yat-sen University, Guangzhou, Guangdong Province, China 3Department of Radiology, Guangzhou Red Cross Hospital/The Fourth Affiliated Hospital of Jinan University Medical College, Guangzhou, Guangdong Province, China 4Department of Burn Surgery, Changhai Hospital, Second Military Medical University, Shanghai, China *These authors have contributed equally to this work Correspondence to: Chan Xie, e-mail: happyxiechan@hotmail.com Zhiliang Gao, e-mail: gaozl@yahoo.com.cn Keywords: microRNA, human hepatocellular carcinoma, cell cycle Received: July 23, 2015 Accepted: September 30, 2015 Published: October 19, 2015 ABSTRACT Aims: To identify the clinical and functional association of miR-214/199a/199a* cluster in human hepatocellular carcinoma (HCC) and to clarify the mechanism of miR-214. Methods: Kaplan-Meier and Cox proportional regression analyses were used to determine the association of miR-214/199a/199a* cluster levels with the survival of HCC patients. The role of miR-214 in regulating HCC cell proliferation was studied with miR-214 mimics/inhibitor-treated cells. Furthermore, the inhibition effect of miR-214 on E2F2, cyclin-dependent kinase (CDK) 3 and CDK6 expression was assessed in HCC cell lines with miR-214 mimics/inhibitors to increase/decrease miR-214 expression. Direct binding of miR-214 to the 3′-untranslated regions of E2F2, CDK3, and CDK6 was verified by dual-luciferase reporter assay. Results: In analyzing HCC clinical specimens and cell lines, we discovered a uniform decrease in miR-214/199a/199a* expression in comparison with noncancerous tissue or normal liver epithelial cell lines. Higher miR-214 levels were related with improved patient survival. Overexpression of miR-214 in HCC cells inhibited proliferation by inducing G1-S checkpoint arrest. Conversely, RNA interference–mediated silencing of miR-214 promoted cell-cycle progression and accelerated the proliferation of HCC cells. E2F2, CDK3 and CDK6 were each directly targeted for inhibition by miR-214, and restoring their expression reversed miR-214 inhibition of cell-cycle progression. The relationship between expression of miR-214 and its targets was confirmed in HCC tumor xenografts and clinical specimens. Conclusions: Our results demonstrate that miR-214 has tumor-suppressive activity in HCC through inhibition of E2F2, CDK3 and CDK6.

13 September 2021 in Langmuir
Verified
Journal Article
Closed access
QWQian Wang
Qian Wang
ZGZhiliang Gao
Zhiliang Gao
QZQi-Zhi Zhong
Qi-Zhi Zhong
NWNing Wang
Ning Wang
HMHanxiao Mei
Hanxiao Mei
JHJingcheng Hao
Jingcheng Hao

16 December 2021 in Polymer Chemistry
Verified
Journal Article
Closed access
PDF file
KZKaijie Zhao
Kaijie Zhao
ZGZhiliang Gao
Zhiliang Gao
DSDongpo Song
Dongpo Song
PZPeiyu Zhang
Peiyu Zhang
JCJiwei Cui
Jiwei Cui
Therapeutic nanoparticles (NPs) have shown their potential for biomedical applications (e.g., drug delivery). In this study, we report the synthesis of a bottlebrush block copolymer by ring opening metathesis polymerization (ROMP) and fabrication of pH-responsive NPs (denoted as BNPs) by self-assembly of an innovative bortezomib (BTZ) prodrug. The cleavage of borate ester bonds at acidic pH results in the release of BTZ from BNPs. Moreover, BNPs can inhibit cell and tumor growth without significant side effects.